Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 20451Q104 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Susquehanna Securities, LLC
13G
|
7.5% |
8/14/2026
Event 6/30/2026
|
|
| G1 Execution Services, LLC | 7.5% | ||
| SIG Brokerage, LP | 7.5% | ||
| Susquehanna Securities, LLC | 7.5% | ||
|
Divisadero Street Capital Management, LP
13G/A
Amendment 1
|
1.1% |
8/14/2026
Event 6/30/2026
|
|
| Divisadero Street Capital Management, LP | 1.1% | ||
| William Zolezzi | 1.1% | ||
| Divisadero Street Partners, L.P. | 1.1% | ||
| Divisadero Street Partners GP, LLC | 1.1% | ||
| Divisadero Street Capital, LLC | 1.1% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 6
|
5.4% |
8/14/2026
Event 6/30/2026
|
|
| American Century Investment Management, Inc. | 5.4% | ||
| American Century Companies, Inc. | 5.4% | ||
| Stowers Institute for Medical Research | 5.4% | ||
| Allspring Global Investments Holdings, LLC 13G/A Amendment 2 | 5.1% |
7/31/2026
Event 6/30/2026
|
|
| BlackRock, Inc. 13G | 5.3% |
7/27/2026
Event 6/30/2026
|
|
|
ADW Capital Partners, L.P.
13D/A
Amendment 5
|
19.3% |
7/16/2026
Event 7/16/2026
|
|
| ADW Capital Partners, L.P. | 19.3% | ||
| ADW Capital Management, LLC | 19.3% | ||
| Adam D. Wyden | 19.3% | ||
|
ADW Capital Partners, L.P.
13D/A
Amendment 4
|
19.3% |
6/2/2026
Event 5/29/2026
|
|
| ADW Capital Partners, L.P. | 19.3% | ||
| ADW Capital Management, LLC | 19.3% | ||
| Adam D. Wyden | 19.3% | ||
|
ADW Capital Partners, L.P.
13D/A
Amendment 3
|
17.9% |
5/11/2026
Event 5/7/2026
|
|
| ADW Capital Partners, L.P. | 17.9% | ||
| ADW Capital Management, LLC | 17.9% | ||
| Adam D. Wyden | 17.9% | ||
|
Divisadero Street Capital Management, LP
13G
|
5.4% |
5/7/2026
Event 4/30/2026
|
|
| Divisadero Street Capital Management, LP | 5.4% | ||
| William Zolezzi | 5.4% | ||
| Divisadero Street Partners, L.P. | 5.4% | ||
| Divisadero Street Partners GP, LLC | 5.4% | ||
| Divisadero Street Capital, LLC | 5.4% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 4.9% |
4/27/2026
Event 3/31/2026
|
|
|
ADW Capital Partners, L.P.
13D/A
Amendment 2
|
14.0% |
4/6/2026
Event 4/2/2026
|
|
| ADW Capital Partners, L.P. | 14.0% | ||
| ADW Capital Management, LLC | 14.0% | ||
| Adam D. Wyden | 14.0% | ||
|
ADW Capital Partners, L.P.
13D/A
Amendment 1
|
9.9% |
3/30/2026
Event 3/26/2026
|
|
| ADW Capital Partners, L.P. | 9.9% | ||
| ADW Capital Management, LLC | 9.9% | ||
| Adam D. Wyden | 9.9% | ||
|
ADW Capital Partners, L.P.
13D
|
7.6% |
2/25/2026
Event 2/23/2026
|
|
| ADW Capital Partners, L.P. | 7.6% | ||
| ADW Capital Management, LLC | 7.6% | ||
| Adam D. Wyden | 7.6% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 5
|
6.6% |
11/14/2025
Event 9/30/2025
|
|
| American Century Capital Portfolios, Inc. | 4.3% | ||
| American Century Investment Management, Inc. | 6.6% | ||
| American Century Companies, Inc. | 6.6% | ||
| Stowers Institute for Medical Research | 6.6% | ||
| Vanguard Group Inc 13G/A Amendment 4 | 3.8% |
10/30/2025
Event 9/30/2025
|
|
| Vanguard Group Inc 13G/A Amendment 3 | 5.6% |
7/29/2025
Event 6/30/2025
|
|
| Allspring Global Investments Holdings, LLC 13G/A Amendment 1 | 6.4% |
4/15/2025
Event 3/31/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 18 | 167 k | $1.82 M |
| 2026 Q2 | 198 | 56.3 M | $604 M |
| 2026 Q1 | 185 | 56.7 M | $447 M |
| 2025 Q4 | 183 | 51.4 M | $246 M |
| 2025 Q3 | 228 | 49.1 M | $326 M |
| 2025 Q2 | 238 | 49.5 M | $312 M |
| 2025 Q1 | 248 | 44.8 M | $837 M |
| 2024 Q4 | 236 | 44.8 M | $1.03 B |
| 2024 Q3 | 216 | 44.1 M | $976 M |
| 2024 Q2 | 222 | 44.7 M | $978 M |
| 2024 Q1 | 220 | 42.6 M | $1.03 B |
| 2023 Q4 | 203 | 41.8 M | $939 M |
| 2023 Q3 | 196 | 37.0 M | $693 M |
| 2023 Q2 | 183 | 36.7 M | $796 M |
| 2023 Q1 | 190 | 36.0 M | $687 M |
| 2022 Q4 | 194 | 36.7 M | $669 M |
| 2022 Q3 | 189 | 35.1 M | $634 M |
| 2022 Q2 | 191 | 34.5 M | $740 M |
| 2022 Q1 | 188 | 29.5 M | $701 M |
| 2021 Q4 | 201 | 26.8 M | $820 M |
| 2021 Q3 | 177 | 22.9 M | $646 M |
| 2021 Q2 | 166 | 21.9 M | $558 M |
| 2021 Q1 | 167 | 22.0 M | $510 M |
| 2020 Q4 | 157 | 21.6 M | $420 M |
| 2020 Q3 | 145 | 19.7 M | $376 M |
| 2020 Q2 | 152 | 19.7 M | $339 M |
| 2020 Q1 | 157 | 18.4 M | $247 M |
| 2019 Q4 | 161 | 18.1 M | $449 M |
| 2019 Q3 | 143 | 18.1 M | $357 M |
| 2019 Q2 | 147 | 18.9 M | $361 M |
| 2019 Q1 | 129 | 19.0 M | $299 M |
| 2018 Q4 | 134 | 20.0 M | $250 M |
| 2018 Q3 | 134 | 20.7 M | $376 M |
| 2018 Q2 | 128 | 20.4 M | $397 M |
| 2018 Q1 | 128 | 22.2 M | $364 M |
| 2017 Q4 | 110 | 20.8 M | $353 M |
| 2017 Q3 | 109 | 20.0 M | $356 M |
| 2017 Q2 | 113 | 19.9 M | $347 M |
| 2017 Q1 | 119 | 22.4 M | $362 M |
| 2016 Q4 | 124 | 21.8 M | $395 M |
| 2016 Q3 | 100 | 19.5 M | $339 M |
| 2016 Q2 | 110 | 19.4 M | $322 M |
| 2016 Q1 | 98 | 19.2 M | $301 M |
| 2015 Q4 | 96 | 19.2 M | $306 M |
| 2015 Q3 | 99 | 18.9 M | $304 M |
| 2015 Q2 | 99 | 18.7 M | $306 M |
| 2015 Q1 | 101 | 18.4 M | $321 M |
| 2014 Q4 | 114 | 18.4 M | $305 M |
| 2014 Q3 | 91 | 16.2 M | $288 M |
| 2014 Q2 | 95 | 16.1 M | $297 M |
| 2014 Q1 | 99 | 15.1 M | $290 M |